GlassScriptPhysician profile
Angela Odoerfer
NPI 1659963916
$7,914.03
in general payments reported to CMS, 2019-2025
16 companies · $2,461 in 2025
The $2,461 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,594 · 2024: $3,858 · 2025: $2,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,295 · Education: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,294.76 |
| Education | $619.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,725.79 | 2023-2025 | |
| Lilly USA, LLC | $1,109.08 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $680.82 | 2023-2025 | |
| Leo Pharma INC. | $607.58 | 2023-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $587.12 | 2023-2025 | Dupixent, Libtayo |
| Ucb, INC. | $560.62 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $533.39 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $516.69 | 2023-2025 | Sotyktu |
| Amgen INC. | $512.32 | 2023-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $275.01 | 2024-2025 | Nemluvio, Aklief |
| Pfizer INC. | $242.74 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $185.16 | 2025 | Zoryve |
| Organon LLC | $151.53 | 2025 | Vtama |
| Incyte Corporation | $125.99 | 2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $71.69 | 2024-2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $28.50 | 2025 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Odoerfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.